Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study

Table 2

Clinical characteristics and laboratory findings of COVID-19 patients with and without diabetes in different gender.

Patients with diabetes
	Total; ()	Male; ()	Female; ()	value
Laboratory findings
γ-Glutamyl transpeptidase, IU/L	38.55 (21.00-70.25)	56.40 (24.00-72.00)	25.00 (14.00-38.25)	0.028
Lipase, U/L	44.30 (38.60-56.70)	40.70 (35.35-44.65)	53.35 (44.48-80.80)	0.053
Urea, mmol/L	4.10 (2.94-5.72)	5.10 (3.12-6.34)	2.95 (2.57-4.30)	0.015
Creatinine, umol/L	63.00 (50.15-84.40)	71.10 (57.20-89.40)	55.11 (41.38-70.50)	0.034
K, mmol/L	3.94 (3.62-4.12)	3.88 (3.50-4.05)	4.08 (3.79-4.31)	0.035
Platelet distribution width	14.80 (11.85-16.10)	15.90 (12.30-16.20)	12.00 (10.25-15.10)	0.051
Activated partial thromboplastin time, s	29.40 (25.75-34.60)	26.60 (23.83-30.86)	33.40 (30.48-35.50)	0.054
Patients without diabetes
	Total; ()	Male; ()	Female; ()	value
Symptoms and signs
Fatigue	92 (18.70%)	35 (14.23%)	57 (23.17%)	0.011
Anorexia	67 (13.62)	23 (9.35%)	44 (17.88%)	0.006
Laboratory findings
γ-Glutamyl transpeptidase, IU/L	30.00 (19.00-56.00)	32.85 (20.85-56.00)	25.45 (17.00-56.43)	0.017
Uric acid, umol/L	276.36 (216.00-348.04)	296.60 (228.23-369.00)	265.30 (204.04-329.20)	0.01
Creatinine, umol/L	61.61 (52.00-75.00)	65.00 (55.00-76.76)	59.70 (49.26-71.00)	0
Cystatin C, mg/L	0.91 (0.78-1.10)	0.99 (0.80-1.19)	0.88 (0.75-1.01)	0.007
Glomerular filtration rate	111.28 (103.67-120.58)	108.74 (100.45-114.60)	116.4 (104.80-127.64)	0.015
Hemoglobin, g/L	134.00 (121.00-148.00)	137.00 (123.00-148.00)	130.00 (119.50-147.50)	0.038
Mean hemoglobin, pg	30.30 (29.18-31.40)	30.50 (29.40-31.50)	30.10 (28.90-31.30)	0.038
Mean hemoglobin concentration, g/L	335.00 (326.00-344.00)	337.00 (326.25-345.00)	334.00 (325.00-342.00)	0.009